Species tropism of HIV-1 modulated by viral accessory proteins

Frontiers in Microbiology

Volumn 3, Issue JUL, 2012, Pages

  Nomaguchi, Masako ^a   Doi, Naoya ^a   Matsumoto, Yui ^a   Sakai, Yosuke ^a   Fujiwara, Sachi ^a   Adachi, Akio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Accessory protein; HIV 1; Species tropism; Vif; Vpu

Indexed keywords

EID: 84875767650     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00267     Document Type: Review

References (41)

1. Arias, J. F., Iwabu, Y., and Tokunaga, K. (2011). Structural basis for the antiviral activity of BST-2/tetherin and its viral antagonism. Front.Microbiol. 2:250. doi: 10.3389/fmicb.2011.00250
2. Berger, G., Durand S., Fargier, G., Nguyen, X.-N., Cordeil, S., Bouaziz, S., Muriaux, D., Darlix, J.-L., and Cimarelli, A. (2011). APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 7, e1002221. doi: 10.1371/journal.ppat.1002221
3. Doi, N., Fujiwara, S., Adachi, A., and Nomaguchi, M. (2011). Rhesus M1.3S cells suitable for biological evaluation of macaquetropic HIV/SIV clones. Front. Microbiol. 2:115. doi: 10.3389/fmicb.2011. 00115
4. Dorfman, T., and Gottlinger, H. G. (1996). The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J. Virol. 70,5751-5757.
5. Douglas, J. L., Gustin, J. K., Viswanathan, K., Mansouri, M., Moses, A. V., and Fruh, K. (2010). The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog. 6, e1000913. doi: 10.1371/journal. ppat.1000913
6. Evans, D. T., Serra-Moreno, R., Singh, R. K., and Guatelli, J. C. (2010). BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 18,388-396.
7. Fujita, M., Otsuka, M., Miyoshi, M., Khamsri, B., Nomaguchi, M., and Adachi, A. (2008). Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages. J. Virol. 82,7752-7756.
8. Fujita, M., Otsuka, M., Nomaguchi, M., and Adachi, A. (2010). Multifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions. Rev. Med. Virol. 20, 68-76.
9. Hatziioannou, T., Ambrose, Z., Chung, N. P. Y., Piatak, M. Jr., Yuan, F., Trubey, C. M., Coalter, V., Kiser, R., Schneider, D., Smedley, J., Pung, R., Gathuka, M., Estes, J. D., Veazey, R. S., KewalRamani, V. N., Lifson, J. D., andBieniasz,P.D. (2009). Amacaque model of HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 106,4425-4429.
10. Hatziioannou, T., Princiotta, M., Piatak, M. Jr., Yuan, F., Zhang, F., Lifson, J. D., and Bieniasz, P. D. (2006). Generation of simantropic HIV-1 by restriction factor evasion. Science 314,95.
11. Holmes, R. K., Malim, M. H., and Bishop, K. N. (2007). APOBEC-mediated viral restriction: not simply editing? Trends Biochem. Sci. 32, 118-128.
12. Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., and Skowronski, J. (2011). Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661.
13. Huthoff, H., and Towers, G. J. (2008). Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha. Trends Microbiol. 16, 612-619.
14. Igarashi, T., Iyengar, R., Byrum, R. A., Buckler-White, A., Dewar, R. L., Buckler, C. E., Lane, H. C., Kamada, K., Adachi, A., and Martin, M. A. (2007). Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pigtailed macaques. J. Virol. 81, 11549-11552.
15. Kamada, K., Igarashi, T., Martin, M. A., Khamsri, B., Hatcho, K., Yamashita, T., Fujita, M., Uchiyama, T., and Adachi, A. (2006). Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl Acad. Sci. U.S.A. 103, 16959-16964.
16. Khamsri, B., Murao, F., Yoshida, A., Sakurai, A., Uchiyama, T., Shirai, H., Matsuo, Y., Fujita, M., and Adachi, A. (2006). Comparative study on the structure and cytopathogenic activity of HIV Vpx/Vpr proteins. Microbes Infect. 8, 10-15.
17. Kirchhoff, F. (2009). Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution? Nat. Rev. Microbiol. 7,467-476.
18. Kitamura, S., Ode, H., and Iwatani, Y. (2011). Structual features of antiviral APOBEC3 proteins are linked to their functional activities. Front. Microbiol. 2:258. doi: 10.3889/fmicb. 2011.00258
19. Kuroishi, A., Saito, A., Shingai, Y., Shioda, T., Nomaguchi, M., Adachi, A., Akari, H., and Nakayama, E. E. (2009). Modification of a loop sequensce between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) Vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells. Retrovirology 6, 70.
20. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Segeral, E., Yatim, A., Emiliani, S., Schwartz, O., and Benkirane, M. (2011). SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657.
21. Malim, M. H., and Emerman, M. (2008). HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3, 388-398.
22. Nakayama, E. E., and Shioda, T. (2012). TRIM5α and species tropism of HIV/SIV. Front. Microbiol. 3:13. doi: 10.3389/fmicb.2012.00013
23. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008). Tether ininhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430.
24. Nomaguchi, M., Doi, N., Kamada, K., and Adachi, A. (2008). Species barrier of HIV-1 and its jumping by virus engineering. Rev. Med. Virol. 18, 261-275.
25. Nomaguchi, M., Fujita, M., and Adachi, A. (2011). The fourth major restriction factor against HIV/SIV. Front. Microbiol. 2:132. doi: 10.3389/fmicb.2011.00132
26. Saito, A., Nomaguchi, M., Iijima, S., Kuroishi, A., Yoshida, T., Lee, Y. J., Hayakawa, T., Kono, K., Nakayama, E. E., Shioda, T., Yasutomi, Y., Adachi, A., Matano, T., and Akari, H. (2011). Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications. Microbes Infect. 13, 58-64.
27. Sakuma, R., and Takeuchi, H. (2012). SIV replication in human cells. Front. Microbiol. 3:162. doi: 10.3389/fmicb.2012.00162
28. Sato, K., Gee, P., and Koyanagi, Y. (2012). Vpu and BST-2: still not there yet? Front. Microbiol. 3:131. doi: 10.3389/fmicb.2012.00131
29. Sauter, D., Schindler, M., Specht, A., Landford, W. N., Munch, J., Kim, K.-A., Votteler, J., Schubert, U., Bibollet-Ruche, F., Keele, B. R. F., Takehisa, J., Ogando, Y., Ochsenbauer, C., Kappes, J. C., Ayouba, A., Peeters, M., Learn, G. H., Shaw, G., Sharp, P. M., Bieniasz, P., Hahn, B. H., Hatziioannou, T., and Kirchhoff, F. (2009). Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6, 409-421.
30. Sauter, D., Specht, A., and Kirchhoff, F. (2010). Tetherin: holding on and letting go. Cell 141, 392-398.
31. Sharp, P. M., and Hahn, B. H. (2011). Origins of HIV and the AIDS pandemic. Cold Spring Harb. Perspect. Med. 1,a006841.
32. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
33. Shibata, R., and Adachi, A. (1992). SIV/HIV recombinants and their use in studying biological properties. AIDS Res. Hum. Retroviruses 8, 403-409.
34. Shibata, R., Kawamura, M., Sakai, H., Hayami, M., Ishimoto, A., and Adachi, A. (1991). Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.J. Virol. 65,3514-3520.
35. Shibata, R., Sakai, H., Kawamura, M., Tokunaga,K., and Adachi, A. (1995). Early replication block of human immunodeficiency type 1 in monkey cells. J. Gen. Virol. 76, 2723-2730.
36. Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., and Skowronski, J. (2008). Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable to enhance macrophage infection. PLoS Pathog. 4, e 1000059. doi: 10.1371/journal.ppat.1000059
37. Strebel, K., Luban, J., and Jeang, K. T. (2009). Human cellular restriction factors that target HIV-1 replication. BMCMed. 7, 48. doi: 10.1186/1741-7015-7-48
38. Thippeshappa, R., Polacino, P., Kimata, M. T. Y., Siwak, E. B., Anderson, D., Wang, W., Sherwood, L., Arora, R., Wen, M., Zhou, P., Hu, S.-L., and Kimata, J. T. (2011). Vif substitution enables persistent infection of pigtailed macaques by human immunodeficiency virus type 1. J. Virol. 85, 3767-3779.
39. Tokarev, A., Skasko, M., Fitzpatrick, K., and Guatelli, J. (2009). Antiviral activity of the interferon-induced cellular protein BST-2/tetherin. AIDS Res. Hum. Retroviruses 25, 11971210.
40. Ueno, F., Shiota, H., Miyaura, M., Yoshida, A., Sakurai, A., Tatsuki, J., Koyama, A. H., Akari, H., Adachi, A., and Fujita, M. (2003). Vpx and Vpr proteins up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells. Microbes Infect. 5, 387-395.
41. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., and Guatelli, J. (2008). The interferon-induced protein BST-2 restricts HIV-1 release and is down-regulated from the cell surface by the Vpu protein. Cell Host Microbe 3, 245-252.